BeStock  
Stocks › Biotechnology › NVCT

Nuvectis Pharma NVCT

US equityMarket cap rank #3422Biotechnology
$19.39 −$0.45 (-2.27%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $19.39 0.00%
Open$19.60
Prev close$19.84
Day range$19.02 – $20.18
Volume301.6K
Market cap$666.80M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-10.1x
CheapRich

Below its usual level · 22nd percentile, 5-year average -7.4x

Price / book5.5x
CheapRich

Near the bottom of its 5-year range · 10th percentile, 5-year average 14.4x

#4469 of 5328 stocks by PB (1 = cheapest)

P/E over five years

-21x-10x1x12xFeb '22Jun '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$34.22
Price vs. fair value-43.3%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 5.50 – 14.37 10% (cheaper than usual) #4469 of 5328 (1 = cheapest)
PE -10.12 -14.50 -7.38 22% (cheaper than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on NVCT.

Sign in to join the discussion.

Scroll to Top